Veraxa Biotech AG - Post de-SPAC (VRXA) Payables (2024 - 2025)
Veraxa Biotech AG - Post de-SPAC's Payables was $2.99 million in the quarter ended Dec 31, 2025, up 436.4% from $557,683 a year earlier.
Powered by 
Analysis
Veraxa Biotech AG - Post de-SPAC (VRXA) Payables (2024 - 2025) Analysis & Trends
As of Dec 31, 2025, Payables at Veraxa Biotech AG - Post de-SPAC came in at $2.88 million, up 419.3% from the prior year.
- In earlier years, Payables was $555,328 in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Veraxa Biotech AG - Post de-SPAC | 16.07 Mn | 12.50 Mn | - | 3.02 Mn |
API Access
Veraxa Biotech AG - Post de-SPAC Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=VRXA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "VRXA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=VRXA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();